SUBSCRIPTION AGREEMENTSubscription Agreement • September 13th, 2017 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 13th, 2017 Company Industry Jurisdiction
LAIDLAW & COMPANY (UK) LTD. New York, NY 10036 W1S 4NS London * Member FINRA, SIPC* *Incorporated in England & Wales: Company No. 3870324*Engagement Agreement • September 13th, 2017 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 13th, 2017 Company Industry JurisdictionPursuant to this exclusive ENGAGEMENT AGREEMENT (the “Agreement”) by and between Laidlaw & Company (UK) Ltd., a United Kingdom corporation with offices at 546 Fifth Ave, New York, New York 10036 (“Laidlaw”) and MabVax Therapeutics Holdings, Inc. (the “Client”, “MBVX” or the "Company"), Laidlaw is engaged by the Client, on an exclusive basis, to perform the services (the “Services”) agreed to hereby on the terms set forth herein.